Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function
Who is this study for? Patients with Hepatocellular Carcinoma
Status: Unknown
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
We propose a randomized controlled study to compare the treatment efficacy of microwave ablation to liver resection for hepatocellular carcinoma (HCC) in patients with borderline liver function.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age \>18 years
• HCC amendable for both MWA and liver resection
• Liver function of ALBI Grade 2
• Tumour size \</= 5cm
• Absence of extrahepatic metastasis
• Absence of radiology evidence of major vascular or bile duct invasion
Locations
Other Locations
Hong Kong Special Administrative Region
Prince of Wales Hospital
RECRUITING
Shatin
Contact Information
Primary
Chun Yeung, MSc
philipyeung@surgery.cuhk.edu.hk
35053933
Time Frame
Start Date: 2018-05-21
Completion Date: 2025-07
Participants
Target number of participants: 76
Treatments
Experimental: Microwave Ablation
Microwave ablation (MWA) will be performed in patients randomized to this arm.
Active_comparator: Liver Resection
Liver resection will be performed in patients randomized to this arm.
Related Therapeutic Areas
Sponsors
Leads: Chinese University of Hong Kong